[{"id":"78316ab0-ca27-4841-8b3c-30534afe4786","acronym":"","url":"https://clinicaltrials.gov/study/NCT01362790","created_at":"2021-01-18T05:34:37.494Z","updated_at":"2024-07-02T16:36:59.049Z","phase":"Phase 1/2","brief_title":"SS1P and Pentostatin Plus Cyclophosphamide for Mesothelioma","source_id_and_acronym":"NCT01362790","lead_sponsor":"National Cancer Institute (NCI)","biomarkers":" ALK • MSLN","pipe":" | ","alterations":" EGFR mutation • MSLN expression • ALK translocation","tags":["ALK • MSLN"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e EGFR mutation • MSLN expression • ALK translocation"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cyclophosphamide • pentostatin • SS1(dsFv)-PE38 • cyclophosphamide intravenous"],"overall_status":"Completed","enrollment":" Enrollment 55","initiation":"Initiation: 05/11/2011","start_date":" 05/11/2011","primary_txt":" Primary completion: 08/03/2016","primary_completion_date":" 08/03/2016","study_txt":" Completion: 08/07/2017","study_completion_date":" 08/07/2017","last_update_posted":"2019-06-06"},{"id":"2d4e4346-858d-4ce7-9821-d1b0475ea503","acronym":"","url":"https://clinicaltrials.gov/study/NCT01051934","created_at":"2021-01-29T07:00:22.453Z","updated_at":"2024-07-02T16:37:20.322Z","phase":"Phase 1","brief_title":"A Phase I Trial of SS1 (dsFv) PE38 With Paclitaxel, Carboplatin, and Bevacizumab in Subjects With Unresectable Non-Small Cell Lung Adenocarcinoma","source_id_and_acronym":"NCT01051934","lead_sponsor":"National Cancer Institute (NCI)","biomarkers":" MSLN","pipe":" | ","alterations":" MSLN expression","tags":["MSLN"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MSLN expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Avastin (bevacizumab) • carboplatin • paclitaxel • SS1(dsFv)-PE38"],"overall_status":"Completed","enrollment":" Enrollment 2","initiation":"Initiation: 12/29/2009","start_date":" 12/29/2009","primary_txt":" Primary completion: 09/28/2011","primary_completion_date":" 09/28/2011","study_txt":" Completion: 09/28/2011","study_completion_date":" 09/28/2011","last_update_posted":"2017-07-02"}]